Popular on EntSun
- OnDemandChina Connects North American Audiences to Top Chinese Content
- 5th Annual "Spirit of Our Ancestors Festival" Includes Films Featuring Descendant, Smithsonian Museum Curator as Keynote Speaker, and Updated Play
- Couples Connect TV Show Premiers On InspireU Network
- zandifashions.com (888) 692-6000 Woman and Men High Quality Fashion
- New Tobu Railway Tokyo Leisure Facility Openings in 2023
- IOTech Partners With LATERAL.systems To Deliver AgTech And Industry 4.0 Solutions For Sustainable Food Production
- World's First & Only Prenatal Vitamin Designed FOR Vegans by Future Kind
- New Cincinnati Bengals Playoff Win vs. Buffalo Has Amelia,OH Molli's Hair Lab Scoring With Hair Cuts
- As the world reopens, & returns to pre-pandemic life, Vesper Public Relations rises to the occasion
- Seasoned Risk Stalwart Brian Hughes Joins Scienaptic As An Investor And Advisor
Similar on EntSun
- Eddie Turner Ranked #13 On The Power List Of The Top 200 Biggest Voices In Leadership In 2023
- IISE announces leadership election results
- Climate Institute Signs Agreement with Swiss-Based 2000-Watt Smart Cities Association to Promote New Climate Change Programs in the United States
- Wildflower Bee Farm publishes new book "What Grandpa Learned from His Honeybees"
- Calvetta Phair, CEO of America's Workforce Solution, LLC, Charitable Partner - 'The On It Foundation' Qualify to Distribute Google Career Certificates
- IntellaTriage Hires New Director of Clinical Operations
- Dental Tourism is on the Rise and This Dental Hygienist is Providing the Consultations
- New Book Launches to Bestseller Status--Answers the Question "Why Is It So Hard to Find Quality Workers?"
- Retired OC Police Officer Launches Caregiver Consulting Company
- The Anderson Periodontal Wellness Office Now Uses Zirconia Dental Implants to Restore Smiles!
Beneficience.com Legacy PR Announces Dr. Burd Renowned Diabetes Scientist, Biochemist-entrepreneur and Dexcom Founder, client
EntSun News/10970997
Dr. Burd is a renowned diabetes scientist and biochemist and Founder of Dexcom, the worldwide leader in Continuous Glucose Monitoring (CGM) systems. Get to know him and what good he is doing in the world, and for whom his life work benefits.
SAN DIEGO - EntSun -- About John Burd, PhD:
Dr. Burd is Founder & CEO of Lysulin, Inc and Wonder Spray, llc. In 2017 Dr. Burd founded Lysulin, Inc, developing scientifically proven nutraceutical products to improve the health of people with diabetes. The first patented product, Lysulin®, was launched in January 2018 and is showing remarkable results in clinical studies in lowering HbA1c and glycated proteins, the cause of disease complications. In 2019 Dr. Burd founded Wonder Spray, llc to provide relief for a variety of ailments and skincare problems using a natural and safe chemical that is used by white blood cells to kill all pathogens.
Dr. Burd was previously President & CEO of DexCom, where he directed the company's work to develop, manufacture and market the first long-term implantable glucose sensor for people with diabetes. In April 2005, DexCom completed a successful IPO, valuing the company at over $500 million. In 2020 DexCom had a market cap of over $40 billion. From 1999 to 2004 Dr. Burd was a General Partner of Windamere Venture Partners.
Before founding DexCom, Dr. Burd was the Founder, President, CEO and Chairman of LXN Corporation, which developed and marketed the Duetâ Diabetes Control System to healthcare professionals and the In ChargeÔ Diabetes Control System to the diabetes self-testing market. LXN was sold to Johnson and Johnson in 2000.
More on EntSun News
Previously, Dr. Burd held executive positions at QUIDEL Corporation, where he directed the development of enzyme immunoassay products for the clinical lab, physician's office and OTC markets. Prior to joining QUIDEL, Dr. Burd was Executive Vice President and COO for MAST Immunosystems, Inc. where he was responsible for the company's operations, including research and development, marketing, sales and finance. MAST Immunosystems was purchased by Hitachi Chemical in 1997. Previously, Dr. Burd was involved in other medical product research and development at Miles Laboratories, Inc. (now Bayer Corporation).
Dr. Burd has authored and co-authored over 45 articles and his work in the medical and biotechnology field has led to the filing and ownership of forty patents and the development of many innovative medical products. He graduated from Purdue University with a B.S. in Biochemistry, and earned an M.S. and Ph.D., also in Biochemistry, from the University of Wisconsin. In 2010 Dr. Burd was inducted into the American Association of Clinical Chemistry Hall of Fame and received the Ullman Prize for innovation in clinical chemistry.
Disclaimer: Dr. Burd's published product statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
JOHN F. BURD, Ph.D.
Founder & CEO Lysulin, Inc and Wonder Spray, llc.
4930 Bradshaw Court, San Diego, CA 92130
More on EntSun News
Phone: 619-992-2873
Website: Promotes Healthy Insulin Function and helps maintain healthy A1c (lysulin.com)
Learn more about Dr. Burd's products below...
Insulin resistance: https://www.youtube.com/watch?v=rdiHqff3EY8
Lysulin video: https://www.youtube.com/watch?v=PK3CkMty6RE
Running A1c test: https://tinyurl.com/y379jbla
Wonder Spray:
https://www.youtube.com/channel/UCYFv1jgn3LmADcZklzLbMHA/videos
Follow Burd's PR News at http://Beneficience.com
MEDIA REQUESTS + MEDIA BOOKING: Dr. Burd is available for relevant events, speaking engagements, radio, podcast, television and media opportunities, news interviews, et als. Burd's media contact information is available now by request online at Beneficience.com Legacy PR at https://beneficience.com/?s=Dr.+John+Burd
Dr. Burd is Founder & CEO of Lysulin, Inc and Wonder Spray, llc. In 2017 Dr. Burd founded Lysulin, Inc, developing scientifically proven nutraceutical products to improve the health of people with diabetes. The first patented product, Lysulin®, was launched in January 2018 and is showing remarkable results in clinical studies in lowering HbA1c and glycated proteins, the cause of disease complications. In 2019 Dr. Burd founded Wonder Spray, llc to provide relief for a variety of ailments and skincare problems using a natural and safe chemical that is used by white blood cells to kill all pathogens.
Dr. Burd was previously President & CEO of DexCom, where he directed the company's work to develop, manufacture and market the first long-term implantable glucose sensor for people with diabetes. In April 2005, DexCom completed a successful IPO, valuing the company at over $500 million. In 2020 DexCom had a market cap of over $40 billion. From 1999 to 2004 Dr. Burd was a General Partner of Windamere Venture Partners.
Before founding DexCom, Dr. Burd was the Founder, President, CEO and Chairman of LXN Corporation, which developed and marketed the Duetâ Diabetes Control System to healthcare professionals and the In ChargeÔ Diabetes Control System to the diabetes self-testing market. LXN was sold to Johnson and Johnson in 2000.
More on EntSun News
- Celebrate Valentine's Day in Sustainable Style on a Budget
- The Data Economics Company and Gordian Knot Strategies Announce Enkrateia Climate Investment Decision Support Platform
- DIY Valentine's Day Gift: Made With Love
- Americana Songstress Emma Jo To Release Powerful New Single, 'Straight Into Mine'
- Drilo's Den Signs New Hip Hop Artist, Big9Dawg
Previously, Dr. Burd held executive positions at QUIDEL Corporation, where he directed the development of enzyme immunoassay products for the clinical lab, physician's office and OTC markets. Prior to joining QUIDEL, Dr. Burd was Executive Vice President and COO for MAST Immunosystems, Inc. where he was responsible for the company's operations, including research and development, marketing, sales and finance. MAST Immunosystems was purchased by Hitachi Chemical in 1997. Previously, Dr. Burd was involved in other medical product research and development at Miles Laboratories, Inc. (now Bayer Corporation).
Dr. Burd has authored and co-authored over 45 articles and his work in the medical and biotechnology field has led to the filing and ownership of forty patents and the development of many innovative medical products. He graduated from Purdue University with a B.S. in Biochemistry, and earned an M.S. and Ph.D., also in Biochemistry, from the University of Wisconsin. In 2010 Dr. Burd was inducted into the American Association of Clinical Chemistry Hall of Fame and received the Ullman Prize for innovation in clinical chemistry.
Disclaimer: Dr. Burd's published product statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
JOHN F. BURD, Ph.D.
Founder & CEO Lysulin, Inc and Wonder Spray, llc.
4930 Bradshaw Court, San Diego, CA 92130
More on EntSun News
- Guardians of the Galaxy unite at Motor City Comic Con!
- Melodic Pop/Rock Spectra Yesterdays Fate Gifts Fans With A New Tune
- BayView Entertainment and Paris Films Enter First Look Agreement
- IISE announces leadership election results
- Brian Lottermann Promoted to Agent at Universal Attractions Agency
Phone: 619-992-2873
Website: Promotes Healthy Insulin Function and helps maintain healthy A1c (lysulin.com)
Learn more about Dr. Burd's products below...
Insulin resistance: https://www.youtube.com/watch?v=rdiHqff3EY8
Lysulin video: https://www.youtube.com/watch?v=PK3CkMty6RE
Running A1c test: https://tinyurl.com/y379jbla
Wonder Spray:
https://www.youtube.com/channel/UCYFv1jgn3LmADcZklzLbMHA/videos
Follow Burd's PR News at http://Beneficience.com
MEDIA REQUESTS + MEDIA BOOKING: Dr. Burd is available for relevant events, speaking engagements, radio, podcast, television and media opportunities, news interviews, et als. Burd's media contact information is available now by request online at Beneficience.com Legacy PR at https://beneficience.com/?s=Dr.+John+Burd
Source: Beneficience.com Legacy PR
Filed Under: Business, Celebrities
0 Comments
Latest on EntSun News
- Louisville Riverport Authority Applies To Include South Central Kentucky In Foreign Trade Zone #29 Service Area
- SR Socially Relevant™ Film Festival celebrates its 10th year with 76 new films
- Up-and-coming young actor and JRP client Chase Dillon is set to appear in an upcoming Disney movie
- Futurama, Avatar, Little Mermaid Stars Bring Character Voices To Life At FAN EXPO Portland
- Trampoline Parks Expand into Other Adventure Segments to Create More Excitement for Visitors
- IntellaTriage Hires New Director of Clinical Operations
- Metro Commercial brokers deal for BJ's Wholesale Club in West Palm Beach, FL
- L-Strategies political and business consulting firm launched by partners Angie Wong and Jared Craig with Donna and Stan Fitzgerald
- Zilker Partners Expands Recruiting and Digital Marketing Services to Keep Pace with Changing Business Climate
- Dental Tourism is on the Rise and This Dental Hygienist is Providing the Consultations
- New Book Launches to Bestseller Status--Answers the Question "Why Is It So Hard to Find Quality Workers?"
- "Revival" Catapults To Top 20 On Mediabase & #24 On Billboard Gospel Airplay Charts
- Cascade Asset Management Recognized in 2023 Gartner® Market Guide for IT Asset Disposition Report
- Retired OC Police Officer Launches Caregiver Consulting Company
- William and Bonnie Daniels will be appearing at Motor City Comic Con
- Technology to protect technology — TenCate Advanced Armor USA offers armored optronics casings in the United States
- The Anderson Periodontal Wellness Office Now Uses Zirconia Dental Implants to Restore Smiles!
- Beyond X Chibi Labs Unveil Gravitale
- Paramount Completes Acquisition of First National ATM
- ASI Welcomes New Chief Revenue Officer and Chief Operating Officer